Noticias de AIM_US
Noticias del mercado
Últimas noticias sobre AIM_US — 269 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
AIM ImmunoTech Inc. has officially suspended its equity distribution agreement and will terminate its continuous offering program effective from May 19, 2026.
AIM ImmunoTech Strengthens Equity Position and Financial Flexibility
AIM ImmunoTech Inc. announced an extension to the maturity date of one of its promissory notes.
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
AIM ImmunoTech Inc. Amends Promissory Note Agreement With Streeterville Capital and Extends Maturity Date to June 30, 2027
El aumento del capital contable y la extensión de pagarés fortalecen la capacidad de la compañía para avanzar en la estrategia de desarrollo del cáncer de páncreas...
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
AIM ImmunoTech celebró la Enmienda n.° 2 a su pagaré con Streeterville Capital, extendiendo el vencimiento del pagaré hasta el 30 de junio de 2027. La enmienda agrega una tarifa de extensión de $10,000 al saldo pendiente, que la compañía representó como $1,682,676.16 al momento de la firma. El cambio sigue a un previo…
Página 7 de 14
